MCVEF OTC
Medicover AB (publ)
1W: +0.0%
1M: +0.0%
3M: +0.0%
YTD: +0.0%
1Y: +0.0%
3Y: +117.0%
5Y: -10.3%
$27.25
+0.00 (+0.00%)
Overview
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Income Trends
Revenue
$2.4B
+13.7% ▲
5Y CAGR: +19.0%
Gross Profit
$551M
+22.8% ▲
5Y CAGR: +15.9%
Operating Income
$156M
+121.5% ▲
5Y CAGR: +20.5%
Net Income
$78M
+364.1% ▲
5Y CAGR: +24.6%
EPS (Diluted)
$0.51
+363.6% ▲
5Y CAGR: +21.8%
EBITDA
$378M
+120.6% ▲
5Y CAGR: +20.0%
Profit Margins
Year-over-Year Growth
View Full Income Statement
| Line Item | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| Revenue | $1.4B | $1.5B | $1.7B | $2.1B | $2.4B |
| YoY Growth | +38.0% | +9.6% | +15.6% | +19.8% | +13.7% |
| Cost of Revenue | $982M | $1.2B | $1.4B | $1.6B | $1.8B |
| Gross Profit | $395M | $336M | $359M | $448M | $551M |
| Gross Margin | 28.7% | 22.2% | 20.6% | 21.4% | 23.2% |
| R&D Expenses | $3M | $4M | $0 | $7M | $0 |
| SG&A Expenses | $55M | $64M | $297M | $94M | $395M |
| Operating Expenses | $236M | $279M | $298M | $378M | $395M |
| Operating Income | $159M | $56M | $61M | $70M | $156M |
| Operating Margin | 11.6% | 3.7% | 3.5% | 3.4% | 6.5% |
| Interest Expense | $20M | $35M | $51M | $61M | $64M |
| Income Before Tax | $144M | $20M | $24M | $20M | $98M |
| Tax Expense | $37M | $6M | $5M | $6M | $26M |
| Net Income | $102M | $12M | $18M | $17M | $78M |
| Net Margin | 7.4% | 0.8% | 1.0% | 0.8% | 3.3% |
| EPS (Diluted) | $0.67 | $0.08 | $0.12 | $0.11 | $0.51 |
| EBITDA | $275M | $216M | $257M | $171M | $378M |
| Shares Outstanding | 148M | 149M | 150M | 150M | 151M |